This paper describes the synthesis of some novel azasterols based on (20R,22xi)-5alpha-pregnan-20-(piperidin-2-yl)-3beta,20-diol. These compounds are potential inhibitors of the enzyme sterol 24-methyltransferase (24-SMT), which is a vital enzyme in the biosynthesis of ergosterol and related 24-alkyl sterols. Structure-activity studies were undertaken to understand the important features for activity against the enzyme, with the aim of increasing activity and selectivity. The compounds were evaluated for inhibition of recombinant Leishmania major 24-SMT and the effect of compounds on sterol composition and parasite proliferation. Essentially, compounds which showed good activity against the recombinant enzyme had a significant effect on the sterol composition and growth of parasites. The activity of compounds was found to be related to the basicity and stereochemical location of the nitrogen. Also, presence of an unprotected 3beta-OH seemed to be important for activity. However, some azasterols which were not good inhibitors of 24-SMT also showed antiproliferative activity, suggesting that there may be other modes of actions of these compounds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm021114j | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression of concern: "Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study" [Int. J. Biol. Macromol. Volume 269, Part 1, June 2024, 132034].
Int J Biol Macromol
December 2024
Harnessing computational and experimental approaches to identify potent hits against Leishmania donovani sterol C-24 methyltransferase from ChemBridge library.
Acta Trop
December 2024
Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address:
Leishmaniasis is a neglected tropical disease and is one of the major causes of mortality in poverty-stricken areas. A limited chemotherapeutics arsenal is available to tackle this deadly infection. Thus, identifying novel potent scaffolds using innovative strategies is the need of the hour.
View Article and Find Full Text PDFEnhancement of ROS Production by Catechin Is a Primary Effect of Increased Azole Efficacy in () Cells Lacking the Gene.
Pathogens
September 2024
Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovicova 6, 842 15 Bratislava, Slovakia.
Article Synopsis
- * Research focused on a mutant fungal strain lacking a specific gene involved in ergosterol production, revealing that this strain had increased resistance to common antifungals like azoles and polyenes, but could be inhibited when combined with catechin.
- * The study suggests that using catechin could enhance antifungal treatments, showing promise in reducing mortality in infected models and highlighting the gene as a potential new target for drug development.
Exploring natural product library as potential target against sterol C-24 methyltransferase protein of .
Nat Prod Res
August 2024
Infectious Diseases Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Article Synopsis
- This study investigates natural products for their ability to kill Leishmania parasites, an important area due to the diverse compounds they offer.
- Out of 560 natural molecules tested, 38 showed over 50% effectiveness at a concentration of 50µM, with six showing dose-dependent activity at much lower concentrations.
- Molecular docking revealed that two compounds, shatavarin IV and 6-methoxydihydrochelerythrine, strongly bind to a specific enzyme in the parasite, blocking its sterol biosynthesis and thus inhibiting parasite growth.
Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach.
Acta Trop
October 2024
Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address:
Leishmaniasis is a disease caused by the parasite Leishmania donovani affecting populations belonging to developing countries. The present study explores drug repurposing as an innovative strategy to identify new uses for approved clinical drugs, reducing the time and cost required for drug discovery. The three-dimensional structure of Leishmania donovani Sterol C-24 methyltransferase (LdSMT) was modeled and 1615 FDA-approved drugs from the ZINC database were computationally screened to identify the potent leads.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!